Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.41 |
| ▸ | CHRM5 | P08912 | 2/20 | 0.40 |
| ▸ | CHRM1 | P11229 | 2/20 | 0.40 |
| ▸ | CHRM3 | P20309 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | PGR | P06401 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.40 |
| ▸ | HTR1A | P08908 | 1/20 | 0.40 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.40 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.40 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.40 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.40 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.40 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.40 |
| ▸ | CHRNA10 | Q9GZZ6 | 1/20 | 0.40 |
| ▸ | CHRNA9 | Q9UGM1 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | GALR3 | O60755 | 2/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7759802 | 0.89 | ALDH1A1 (0.45) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL15875781 | 0.86 | ALOX15 (0.48) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL3841838 | 0.85 | ALDH1A1 (0.42) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL10020242 | 0.82 | TDP1 (0.47) | ALDH1A1CHRM5CHRM1CHRM3SMN1; SMN2 | |
| SCHEMBL1054275 | 0.80 | ALDH1A1 (0.48) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL5988620 | 0.80 | ALOX15 (0.44) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL7700789 | 0.80 | ALOX15 (0.44) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL3784335 | 0.78 | ALOX15 (0.56) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL10982034 | 0.78 | ALOX15 (0.43) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 | |
| SCHEMBL8907667 | 0.78 | ALOX15 (0.43) | ALOX15ALDH1A1CHRM5CHRM1CHRM3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8802352-B2 | Salt, photoresist composition and method for producing photoresist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-08-12 | — | — | US | disclosed |
| US-20130040239-A1 | SALT, PHOTORESIST COMPOSITION AND METHOD FOR PRODUCING PHOTORESIST PATTERN | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2013-02-14 | — | — | US | disclosed |
| CN-1206228-C | N-heterocyclic derivatives as NOS inhibitors | BERLEX LAB (US) | 2005-06-15 | — | — | CN | disclosed |
| CN-1136193-C | Imide derivatives or salts thereof | ֮����ҩ��ʽ���� | 2004-01-28 | — | — | CN | disclosed |
| CN-1382136-A | N-heterocyclic derivatives as NOS inhibitors | BERLEX LAB (US) | 2002-11-27 | — | — | CN | disclosed |
| CN-1218045-A | Imide derivatives or salts thereof | YAMANOUCHI PHARMA CO LTD (JP) | 1999-06-02 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130040239-A1 | SALT, PHOTORESIST COMPOSITION AND METHOD FOR PRODUCING PHOTORESIST PATTERN | CRY1, H1-0, SPIN1 | ALOX15 1942/4885ALDH1A1 1898/4885CHRM5 3112/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.